BioSpace News Archive

Agenus Inc. (Nasdaq: AGEN), an immuno-oncology company with a pipeline of immunological agents targeting cancer and infectious disease, today provided a corporate update and reported financial results for the fourth quarter and full year 2022.

Biohaven Ltd. (NYSE: BHVN) announced today that it will present an oral and poster presentation demonstrating the preclinical efficacy and initial Phase 1 safety and tolerability of BHV-7000.

Rune Labs today announced a partnership with BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned, independently operated subsidiary of Bayer AG.

Cogent Biosciences, Inc. today provided a business update and reported financial results for the fourth quarter and full year of 2022.

Ocean Biomedical, Inc., a next generation biopharma company, announces initiation of equity analyst coverage by EF Hutton with a “Buy” recommendation.

Sapience Therapeutics, Inc. announced today that the U.S. Food and Drug Administration (FDA) cleared the Company to proceed with its Phase 1-2 clinical trial of ST316 for the treatment of solid tumors.

ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, and Quantum Leap Healthcare Collaborative (“Quantum Leap”) today announced that the first patient has been dosed in the I-SPY-P1-TRIAL for the treatment of patients with unresectable or metastatic HER2-positive and HER2-low breast cancer.

More than 2 million care providers exchanged patient clinical and benefit information more than 21.7 billion times in 2022, reaching virtually every American patient, according to the Surescripts 2022 National Progress Report.

OneMedNet Corporation announced the Company has built one of the largest and most diverse dataset of breast cancer screenings, a vital tool in early detection of breast cancer.

Halberd Corporation is scheduled to meet with Center of Disease Control representatives to discuss Halberd’s incredible success in eradicating multiple strains of antibiotic resistant E. coli bacteria and Candida auris samples previously provided by the CDC.